Jazz Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference
Jazz Pharmaceuticals (Nasdaq: JAZZ) will participate in Citi's 2025 Global Healthcare Conference. Management will appear in a fireside chat on December 2, 2025 at 6:45 a.m. PST / 9:45 a.m. EST / 2:45 p.m. GMT. An audio webcast of the fireside chat will be available via the Investors section of Jazz Pharmaceuticals' website and a replay will be archived for 30 days.
Jazz Pharmaceuticals is a global biopharma focused on therapies for sleep disorders, epilepsy, and oncology, with R&D, manufacturing, and employees in multiple countries. For investor access, visit the company's investor events and presentations page.
Jazz Pharmaceuticals (Nasdaq: JAZZ) parteciperà al Citi's 2025 Global Healthcare Conference. La direzione parteciperà a un colloquio informale il 2 dicembre 2025 alle 6:45 a.m. PST / 9:45 a.m. EST / 14:45 GMT. Una trasmissione audio del colloquio sarà disponibile tramite la sezione Investitori del sito web di Jazz Pharmaceuticals e una replica sarà archiviata per 30 giorni.
Jazz Pharmaceuticals è una biopharma globale focalizzata su terapie per disturbi del sonno, epilessia e oncologia, con R&D, produzione e dipendenti in diversi paesi. Per l'accesso degli investitori, visitare la pagina eventi e presentazioni per gli investitori dell'azienda.
Jazz Pharmaceuticals (Nasdaq: JAZZ) participará en la Citi's 2025 Global Healthcare Conference. La dirección participará en una charla junto a la chimenea en 2 de diciembre de 2025 a las 6:45 a.m. PST / 9:45 a.m. EST / 2:45 p.m. GMT. Una transmisión en audio de la charla estará disponible a través de la sección de Inversores del sitio web de Jazz Pharmaceuticals y una repetición estará archivada por 30 días.
Jazz Pharmaceuticals es una biopharma global centrada en terapias para trastornos del sueño, epilepsia y oncología, con I+D, fabricación y empleados en varios países. Para acceso de inversores, visite la página de eventos y presentaciones para inversores de la empresa.
Jazz Pharmaceuticals (나스닥: JAZZ)은 Citi의 2025 Global Healthcare Conference에 참가할 예정입니다. 경영진은 2025년 12월 2일 오전 6:45 PST / 오전 9:45 EST / 오후 2:45 GMT에 fireside chat에 출연합니다. fireside chat의 오디오 웹캐스트는 Jazz Pharmaceuticals 웹사이트의 투자자 섹션에서 이용 가능하며 재생은 30일 동안 보관됩니다.
Jazz Pharmaceuticals는 수면 장애, 간질 및 종양학 치료에 중점을 둔 글로벌 바이오파마이며, 다수의 국가에서 R&D, 제조 및 직원이 있습니다. 투자자 접근을 원하면 회사의 투자자 이벤트 및 프레젠테이션 페이지를 방문하십시오.
Jazz Pharmaceuticals (Nasdaq : JAZZ) participera à la Conférence mondiale sur les soins de santé 2025 de Citi. La direction participera à une table ronde informelle lors d'un fireside chat le 2 décembre 2025 à 6h45 PST / 9h45 EST / 14h45 GMT. Une retransmission audio du fireside chat sera disponible via la rubrique Investisseurs du site Web de Jazz Pharmaceuticals et une reprise sera archivée pendant 30 jours.
Jazz Pharmaceuticals est une biopharma mondiale spécialisée dans les thérapies pour les troubles du sommeil, l'épilepsie et l'oncologie, avec la R&D, la fabrication et des employés dans plusieurs pays. Pour accéder aux investisseurs, consultez la page des événements et des présentations destinées aux investisseurs de l'entreprise.
Jazz Pharmaceuticals (Nasdaq: JAZZ) wird an der Citi's 2025 Global Healthcare Conference teilnehmen. Die Geschäftsführung wird an einem Fireside-Chat am 2. Dezember 2025 um 6:45 Uhr PST / 9:45 Uhr EST / 14:45 Uhr GMT teilnehmen. Ein Audio-Webcast des Fireside-Chats wird über den Bereich Investoren der Jazz Pharmaceuticals-Website verfügbar sein, und eine Wiederholung wird für 30 Tage archiviert.
Jazz Pharmaceuticals ist ein globales Biopharma-Unternehmen, das sich auf Therapien bei Schlafstörungen, Epilepsie und Onkologie konzentriert, mit F&E, Herstellung und Mitarbeitern in mehreren Ländern. Für den Investorenzugang besuchen Sie bitte die Seite der Investorenveranstaltungen und Präsentationen des Unternehmens.
Jazz Pharmaceuticals (ناسداك: JAZZ) ستشارك في مؤتمر Citi الصحي العالمي 2025. ستظهر الإدارة في جلسة fireside في 2 ديسمبر 2025 في 6:45 صباحاً بتوقيت المحيط الهادئ / 9:45 صباحاً بتوقيت شرق الولايات المتحدة / 2:45 مساءً بتوقيت GMT. ستتوفر بث صوتي لجلسة fireside عبر قسم المستثمرين في موقع Jazz Pharmaceuticals، وسيتم حفظ إعادة البث لمدة 30 يوماً.
Jazz Pharmaceuticals شركة أدوية حيوية عالمية تركز على علاجات للاضطرابات النوم، والصرع، والأورام، مع البحث والتطوير، والتصنيع، وموظفين في عدة دول. للوصول إلى المستثمرين، يرجى زيارة صفحة فعاليات المستثمرين وعروض الشركات.
- None.
- None.
An audio webcast of the fireside chat will be available via the Investors section of the Jazz Pharmaceuticals website at https://investor.jazzpharma.com/investors/events-presentations. A replay of the webcast will be archived on the website for 30 days.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in
Contacts:
Investors:
Jack Spinks
Executive Director, Investor Relations
Jazz Pharmaceuticals plc
InvestorInfo@jazzpharma.com
Media:
Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc
CorporateAffairsMediaInfo@jazzpharma.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-to-participate-in-citis-2025-global-healthcare-conference-302619149.html
SOURCE Jazz Pharmaceuticals plc